Volume 17
Number 0
Feb 2013
Back to issue
Case Reports
S. van der Sar-van der Brugge, H. van Ravenswaay Claasen, L. Dawson

Bleomycin is an antineoplastic agent that is known for its potential for fatal lung toxicity. Cell injury occurs through the formation of free radicals.
Timely detection of bleomycin-induced pneumonitis (BIP) can be difficult and it is vital to keep a low index of suspicion in patients receiving bleomycin. We describe a patient with Hodgkin’s lymphoma who died of bleomycin-induced lung injury in our intensive care unit. We discuss treatment options and review the literature.


Back to issue - Download PDF